Literature DB >> 9737865

Apolipoprotein B-100 conformation and particle surface charge in human LDL subspecies: implication for LDL receptor interaction.

S Lund-Katz1, P M Laplaud, M C Phillips, M J Chapman.   

Abstract

The plasma low-density lipoprotein (LDL) profile in coronary artery disease patients is characterized by a predominance of small, dense LDL. Small, dense LDL exhibit both high susceptibility to oxidation and low binding affinity for the LDL receptor, suggesting that these particles may be of elevated atherogenic potential. Here we examine whether the variation in biological function is due to differences in apo B-100 conformation that alter the interaction with the cellular LDL receptor. The microenvironments (pKa) of Lys residues in apo B-100 in small, dense, intermediate, and light human LDL subspecies have been compared by 13C NMR, and the net surface charge of these particles has been characterized. Relative to the total LDL fraction, small, dense, and light LDL subspecies have a decreased number of pKa 8.9 Lys, while intermediate density LDL has a consistently higher number of pKa 8.9 Lys. It follows that differences in protein conformation, as reflected in the Lys microenvironments, exist in the different LDL subspecies. Electrophoretic mobility measurements revealed that the light LDL subfractions exhibit a surface charge at pH 8.6 that is from -26 to -34e more negative than the intermediate density LDL subfraction. For the small, dense LDL particles the increments in negative charge range from -7 to -17e relative to the intermediate density LDL subfraction. These results suggest that differences in the conformation of apo B-100 and surface charge between LDL subspecies are major determinants of their catabolic fate. The lower number of pKa 8.9 Lys leads to a reduction in binding of small, dense, and light LDL to the cellular LDL receptor and prolongs their plasma residence time, thereby elevating the atherogenicity of these particles. These data support the proposal that the intermediate LDL subspecies constitute the optimal ligand for the LDL receptor among human LDL particle subpopulations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737865     DOI: 10.1021/bi980828m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  32 in total

1.  Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib.

Authors:  Ronald M Krauss; Kathleen Wojnooski; Joseph Orr; J Casey Geaney; Cathy Anne Pinto; Yang Liu; John A Wagner; Julie Mabalot Luk; Amy O Johnson-Levonas; Matt S Anderson; Hayes M Dansky
Journal:  J Lipid Res       Date:  2011-12-17       Impact factor: 5.922

2.  Hepatic Arterial Infusion of Low-Density Lipoprotein Docosahexaenoic Acid Nanoparticles Selectively Disrupts Redox Balance in Hepatoma Cells and Reduces Growth of Orthotopic Liver Tumors in Rats.

Authors:  Xiaodong Wen; Lacy Reynolds; Rohit S Mulik; Soo Young Kim; Tim Van Treuren; Liem H Nguyen; Hao Zhu; Ian R Corbin
Journal:  Gastroenterology       Date:  2015-10-17       Impact factor: 22.682

3.  Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells.

Authors:  Lacy Reynolds; Rohit S Mulik; Xiaodong Wen; Archana Dilip; Ian R Corbin
Journal:  Nanomedicine (Lond)       Date:  2014-01-07       Impact factor: 5.307

4.  Gold nanocrystal labeling allows low-density lipoprotein imaging from the subcellular to macroscopic level.

Authors:  Iris E Allijn; Wei Leong; Jun Tang; Anita Gianella; Aneta J Mieszawska; Francois Fay; Ge Ma; Stewart Russell; Catherine B Callo; Ronald E Gordon; Emine Korkmaz; Jan Andries Post; Yiming Zhao; Hans C Gerritsen; Axel Thran; Roland Proksa; Heiner Daerr; Gert Storm; Valentin Fuster; Edward A Fisher; Zahi A Fayad; Willem J M Mulder; David P Cormode
Journal:  ACS Nano       Date:  2013-10-17       Impact factor: 15.881

5.  Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents.

Authors:  Gang Zheng; Juan Chen; Hui Li; Jerry D Glickson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-23       Impact factor: 11.205

6.  Elucidating the structural organization of a novel low-density lipoprotein nanoparticle reconstituted with docosahexaenoic acid.

Authors:  Rohit S Mulik; Hui Zheng; Kumar Pichumani; James Ratnakar; Qiu-Xing Jiang; Ian R Corbin
Journal:  Chem Phys Lipids       Date:  2017-03-22       Impact factor: 3.329

7.  Investigation into the distinct subcellular effects of docosahexaenoic acid loaded low-density lipoprotein nanoparticles in normal and malignant murine liver cells.

Authors:  Lacy R Moss; Rohit S Mulik; Tim Van Treuren; Soo Young Kim; Ian R Corbin
Journal:  Biochim Biophys Acta       Date:  2016-07-11

Review 8.  Influence of dietary carbohydrate and fat on LDL and HDL particle distributions.

Authors:  Patty W Siri; Ronald M Krauss
Journal:  Curr Atheroscler Rep       Date:  2005-11       Impact factor: 5.113

9.  Naphthalocyanine-reconstituted LDL nanoparticles for in vivo cancer imaging and treatment.

Authors:  Liping Song; Hui Li; Ulas Sunar; Juan Chen; Ian Corbin; Arjun G Yodh; Gang Zheng
Journal:  Int J Nanomedicine       Date:  2007

Review 10.  Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors.

Authors:  M John Chapman; Wilfried Le Goff; Maryse Guerin; Anatol Kontush
Journal:  Eur Heart J       Date:  2009-10-12       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.